| Bioactivity | Dapiglutide (ZP7570) is a long-acting glucagon-like peptide-1 receptor 1R (GLP-1R)/Glucagon-like peptide-2 receptor (GLP-2R) dual agonist. Dapiglutide can be used for short bowel syndrome (SBS) research[1]. | ||||||
| Name | Dapiglutide | ||||||
| CAS | 2296814-85-0 | ||||||
| Formula | C192H302N46O57 | ||||||
| Molar Mass | 4166.79 | ||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||
| Storage | Sealed storage, away from moisture and light, under nitrogen
*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light, under nitrogen) |
Dapiglutide
CAS: 2296814-85-0 F: C192H302N46O57 W: 4166.79
Dapiglutide (ZP7570) is a long-acting glucagon-like peptide-1 receptor 1R (GLP-1R)/Glucagon-like peptide-2 receptor (GLP
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.